Synthesis and antiviral activity of certain second generation methylenecyclopropane nucleosides. 2012

John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
Microbiotix, Inc., One Innovation Drive, Worcester, MA 01605, USA. jwilliams@microbiotix.com

A second-generation series of substituted methylenecyclopropane nucleosides (MCPNs) has been synthesized and evaluated for antiviral activity against a panel of human herpesviruses, and for cytotoxicity. Although alkylated 2,6-diaminopurine analogs showed little antiviral activity, the compounds containing ether and thioether substituents at the 6-position of the purine did demonstrate potent and selective antiviral activity against several different human herpesviruses. In the 6-alkoxy series, antiviral activity depended on the length of the ether carbon chain, with the optimum chain length being about four carbon units long. For the corresponding thioethers, compounds containing secondary thioethers were more potent than those with primary thioethers.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006564 Herpesviridae A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE. Mouse Thymic Virus,Murid herpesvirus 3,Thymic Group Viruses,Herpesviruses,Mouse Thymic Viruses,Thymic Virus, Mouse,Thymic Viruses, Mouse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
January 2004, Journal of medicinal chemistry,
John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
August 1999, Antiviral research,
John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
January 2005, Nucleosides, nucleotides & nucleic acids,
John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
February 2006, Bioorganic & medicinal chemistry,
John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
February 1977, Journal of medicinal chemistry,
John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
November 1982, Journal of medicinal chemistry,
John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
January 2005, Journal of medicinal chemistry,
John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
January 2003, Nucleosides, nucleotides & nucleic acids,
John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
February 2003, Nucleosides, nucleotides & nucleic acids,
John D Williams, and Atiyya R Khan, and Emma A Harden, and Caroll B Hartline, and Geraldine M Jefferson, and Kathy A Keith, and Mark N Prichard, and Jiri Zemlicka, and Norton P Peet, and Terry L Bowlin
November 2004, Journal of medicinal chemistry,
Copied contents to your clipboard!